| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,340 | 4,560 | 12:37 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.10. | TIGERMED Swings to 9M Loss of RMB272 million | 1 | AASTOCKS | ||
| 29.10. | TIGERMED (03347): 2026 THIRD QUARTERLY REPORT | - | HKEx | ||
| 22.10. | TIGERMED (03347): INSIDE INFORMATION | - | HKEx | ||
| 16.10. | TIGERMED (03347): INSIDE INFORMATION - UPDATE ON INVESTIGATION AGAINST DIRECTORS AND CONTROLLING SHAREHOLDERS | - | HKEx | ||
| HANGZHOU TIGERMED CONSULTING Aktie jetzt für 0€ handeln | |||||
| 16.10. | TIGERMED (03347): DATE OF BOARD MEETING | 1 | HKEx | ||
| 09.10. | TIGERMED (03347): ADJUSTMENTS TO THE LIST OF PARTICIPANTS AND THE NUMBER OF RESTRICTED SHARES GRANTED UNDER THE 2026 RESTRICTED A SHARE INCENTIVE SCHEME ... | 1 | HKEx | ||
| 25.09. | TIGERMED (03347): 2026 INTERIM REPORT | 2 | HKEx | ||
| 23.09. | TIGERMED (03347): ARTICLES OF ASSOCIATION | - | HKEx | ||
| 23.09. | TIGERMED (03347): POLL VOTING RESULTS OF THE 2026 THIRD EXTRAORDINARY GENERAL MEETING, THIRD A SHARE CLASS MEETING AND THIRD H SHARE CLASS MEETING HELD ... | - | HKEx | ||
| 11.09. | TIGERMED (03347): INSIDE INFORMATION - UPDATE ON INVESTIGATION AGAINST DIRECTORS AND CONTROLLING SHAREHOLDERS | 2 | HKEx | ||
| 03.09. | TIGERMED (03347): FORM OF PROXY FOR THE 2026 THIRD H SHARE CLASS MEETING TO BE HELD ON WEDNESDAY, SEPTEMBER 23, 2026 | 1 | HKEx | ||
| 03.09. | TIGERMED (03347): FORM OF PROXY FOR THE 2026 THIRD EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, SEPTEMBER 23, 2026 | - | HKEx | ||
| 03.09. | TIGERMED (03347): NOTICE OF THE 2026 THIRD H SHARE CLASS MEETING | - | HKEx | ||
| 03.09. | TIGERMED (03347): NOTICE OF THE 2026 THIRD EXTRAORDINARY GENERAL MEETING | 3 | HKEx | ||
| 03.09. | TIGERMED (03347): CIRCULAR OF THE 2026 THIRD EGM AND 2026 THIRD H SHARE CLASS MEETING | 2 | HKEx | ||
| 28.08. | TIGERMED (03347): 2026 CHANGE IN USE OF PROCEEDS FROM THE H SHARE OFFERING | 1 | HKEx | ||
| 28.08. | TIGERMED (03347): (1) PROPOSED CANCELLATION OF REPURCHASED SHARES AND PROPOSED REDUCTION OF THE REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS ... | 1 | HKEx | ||
| 28.08. | TIGERMED (03347): (1) PROPOSED ADOPTION OF THE 2026 RESTRICTED A SHARE INCENTIVE SCHEME AND ITS SUMMARY; (2) PROPOSED ADOPTION OF THE MANAGEMENT MEASURES ... | - | HKEx | ||
| 28.08. | Hangzhou Tigermed Consulting Co., Ltd.: Tigermed Announces 2026 Interim Results | 1.355 | PR Newswire | HANGZHOU, China, Aug. 28, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for... ► Artikel lesen | |
| 28.08. | TIGERMED (03347): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 3 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 50,91 | -1,85 % | Aktien Frankfurt: Dax legt zum Monatsanfang im unsicheren Umfeld etwas zu | FRANKFURT (dpa-AFX) - Nach der kleinen Korrektur vom Freitag hat sich der Dax zum Wochenbeginn wieder stabilisiert. Die Ölpreise gingen nach einem Bericht über diplomatische Bemühungen von US-Präsident... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,680 | -3,13 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| INTUITIVE SURGICAL | 411,05 | -1,62 % | ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising? | ||
| DRAEGERWERK | 101,40 | -3,24 % | Carl Zeiss Meditec, Drägerwerk, Sartorius: Wo Analysten das meiste Potenzial sehen | ||
| MEDTRONIC | 92,82 | -0,68 % | Medtronic: She Spent Years Improving Stroke Care, Then It Helped Save Her Sister | NORTHAMPTON, MA / ACCESS Newswire / November 3, 2026 / MedtronicHeather Vannes spent years shaving minutes off stroke care. When her sister collapsed on an ordinary afternoon, every one of those minutes... ► Artikel lesen | |
| THERMO FISHER | 604,60 | +0,17 % | Thermo Fisher Scientific announces $5B share repurchase authorization | ||
| TELADOC HEALTH | 8,180 | -2,62 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | ||
| HIMS & HERS HEALTH | 22,020 | +2,71 % | Novo Nordisk, Eli Lilly und Hims & Hers: So weit liegen Wachstum und Gegenwind bei den Abnehmspritzen auseinander | ||
| M1 AESTHETICS | 13,400 | +1,52 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| BECTON DICKINSON | 190,25 | 0,00 % | Becton, Dickinson And Company Q4 Profit Advances | WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line totaled $696 million... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,071 | 0,00 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 65,86 | 0,00 % | Guggenheim raises BrightSpring Health stock price target on growth | ||
| SIEMENS HEALTHINEERS | 43,800 | -1,71 % | Anleger reagieren nervös: Schwächelnde Zahlen: Kommt die Siemens-Abspaltung zur Unzeit? | © Foto: Daniel Karmann/dpa Siemens Healthineers hat das Geschäftsjahr 2026 erfolgreich abgeschlossen. Doch die Prognose für 2027 enttäuscht. Vor allem China bleibt ein Problem Enthaltene Werte: DE000SHL1006... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,410 | -0,15 % | LifeStance Health Group Q3 2026 Earnings Preview | ||
| PROCEPT BIOROBOTICS | 20,270 | 0,00 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 |